Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway

Nature Genetics

Volumn 46, Issue 8, 2014, Pages 872-876

  Li, Maolan ^a,b   Zhang, Zhou ^a,b   Li, Xiaoguang ^c   Ye, Junyi ^d   Wu, Xiangsong ^a,b   Tan, Zhujun ^a,b   Liu, Chang ^e   Shen, Baiyong ^a   Wang, Xu An ^a,b   Wu, Wenguang ^a,b   Zhou, Daizhan ^a   Zhang, Di ^a   Wang, Ting ^a   Liu, Bingya ^a   Qu, Kai ^e   Ding, Qichen ^a,b   Weng, Hao ^a,b   Ding, Qian ^a,b   Mu, Jiasheng ^a,b   Shu, Yijun ^a,b   Bao, Runfa ^a,b   Cao, Yang ^a,b   Chen, Peizhan ^c   Liu, Tianyu ^a,b   Jiang, Lin ^a,b   Hu, Yunping ^a,b   Dong, Ping ^a,b   Gu, Jun ^a,b   Lu, Wei ^a,b   Shi, Weibin ^a,b   Lu, Jianhua ^a,b   Gong, Wei ^a,b   Tang, Zhaohui ^a,b   Zhang, Yong ^a,b   Wang, Xuefeng ^a,b   Chin, Y Eugene ^f   Weng, Xiaoling ^d   Zhang, Hong ^d   Tang, Wei ^g   Zheng, Yonglan ^h   He, Lin ^a,d,i   Wang, Hui ^c,j   Liiu, Yun ^d   Liu, Yingbin ^a,b   more..

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^d FUDAN UNIVERSITY   (China)

^e XI'AN JIAOTONG UNIVERSITY   (China)

^f Chinese Academy of Sciences   (China)

^g NATIONAL CANCER INSTITUTE   (United States)

^h UNIVERSITY OF CHICAGO   (United States)

ⁱ ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^j BEIJING HOSPITAL   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTIDINE DEAMINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; K RAS PROTEIN; PROTEIN P53; VASCULOTROPIN RECEPTOR; EGFR PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CELL VIABILITY; DNA END JOINING REPAIR; EXOME; FEMALE; GALLBLADDER CARCINOMA; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RNA INTERFERENCE; SOMATIC MUTATION; CARCINOMA; CELL LINE; ENZYMOLOGY; GALLBLADDER TUMOR; GENETICS; HEK293 CELL LINE; HIGH THROUGHPUT SEQUENCING; MIDDLE AGED; MUTATION; PROCEDURES; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CELL LINE; CELL LINE, TUMOR; EXOME; FEMALE; GALLBLADDER NEOPLASMS; HEK293 CELLS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MIDDLE AGED; MUTATION; NEOPLASM RECURRENCE, LOCAL; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 84905721813     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.3030     Document Type: Article

References (34)

1. Randi, G., Franceschi, S. & La Vecchia, C. Gallbladder cancer worldwide: Geographical distribution and risk factors. Int. J. Cancer 118, 1591-1602 (2006
2. Srivastava, K., Srivastava, A., Sharma, K.L. & Mittal, B. Candidate gene studies in gallbladder cancer: A systematic review and meta-Analysis. Mutat. Res. 728, 67-79 (2011
3. Wolpin, B.M. & Mayer, R.J. A step forward in the treatment of advanced biliary tract cancer. N. Engl. J. Med. 362, 1335-1337 (2010
4. Boutros, C., Gary, M., Baldwin, K. & Somasundar, P. Gallbladder cancer: Past, present and an uncertain future. Surg. Oncol. 21, e183-e191 (2012
5. Maurya, S.K., Tewari, M., Mishra, R.R. & Shukla, H.S. Genetic aberrations in gallbladder cancer. Surg. Oncol. 21, 37-43 (2012
6. Jiao, Y. et al. Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas. Nat. Genet. 45, 1470-1473 (2013
7. Cingolani, P. et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin) 6, 80-92 (2012
8. Alexandrov, L.B. et al. Signatures of mutational processes in human cancer. Nature 500, 415-421 (2013
9. Li, M. & Liu, Y. The applications of exome sequencing in the study of gastrointestinal cancer. Chin. J. Pract. Surg. 33, 414-416 (2013
10. Lawrence, M.S. et al. Mutational heterogeneity in cancer and the search for new cancer-Associated genes. Nature 499, 214-218 (2013
11. Roberts, S.A. et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat. Genet. 45, 970-976 (2013
12. Kuong, K.J. & Loeb, L.A. APOBEC3B mutagenesis in cancer. Nat. Genet. 45, 964-965 (2013
13. Dees, N.D. et al. MuSiC: Identifying mutational significance in cancer genomes. Genome Res. 22, 1589-1598 (2012
14. Wong, K.M., Hudson, T.J. & McPherson, J.D. Unraveling the genetics of cancer: Genome sequencing and beyond. Annu. Rev. Genomics Hum. Genet. 12, 407-430 (2011
15. Wistuba, I.I. & Gazdar, A.F. Gallbladder cancer: Lessons from a rare tumour. Nat. Rev. Cancer 4, 695-706 (2004
16. Croce, C.M. Oncogenes and cancer. N. Engl. J. Med. 358, 502-511 (2008
17. Jaiswal, B.S. et al. Oncogenic ERBB3 mutations in human cancers. Cancer Cell 23, 603-617 (2013
18. Desai, M.D., Saroya, B.S. & Lockhart, A.C. Investigational therapies targeting the ErbB (EGFR, HER2, HER3, HER4) family in GI cancers. Expert Opin. Investig. Drugs 22, 341-356 (2013
19. Nakazawa, K. et al. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers. J. Pathol. 206, 356-365 (2005
20. Kiguchi, K. et al. Constitutive expression of ErbB-2 in gallbladder epithelium results in development of adenocarcinoma. Cancer Res. 61, 6971-6976 (2001
21. Baselga, J. & Swain, S.M. Novel anticancer targets: Revisiting ERBB2 and discovering ERBB3. Nat. Rev. Cancer 9, 463-475 (2009
22. Sliwkowski, M.X. Ready to partner. Nat. Struct. Biol. 10, 158-159 (2003
23. Franklin, M.C. et al. Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex. Cancer Cell 5, 317-328 (2004
24. Macdonald-Obermann, J.L., Adak, S., Landgraf, R., Piwnica-Worms, D. & Pike, L.J. Dynamic analysis of the epidermal growth factor (EGF) receptor-ErbB2-ErbB3 protein network by luciferase fragment complementation imaging. J. Biol. Chem. 288, 30773-30784 (2013
25. Pignochino, Y. et al. Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas. BMC Cancer 10, 631 (2010
26. Goldin, R.D. & Roa, J.C. Gallbladder cancer: A morphological and molecular update. Histopathology 55, 218-229 (2009
27. Lohse, M. et al. RobiNA: A user-friendly, integrated software solution for RNA-Seq-based transcriptomics. Nucleic Acids Res. 40, W622-W627 (2012
28. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009
29. McKenna, A. et al. The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297-1303 (2010
30. Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213-219 (2013
31. Ye, K., Schulz, M.H., Long, Q., Apweiler, R. & Ning, Z. Pindel: A pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics 25, 2865-2871 (2009
32. Adzhubei, I.A. et al. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248-249 (2010
33. Choi, Y., Sims, G.E., Murphy, S., Miller, J.R. & Chan, A.P. Predicting the functional effect of amino acid substitutions and indels. PLoS ONE 7, e46688 (2012
34. Wendl, M.C. et al. PathScan: A tool for discerning mutational significance in groups of putative cancer genes. Bioinformatics 27, 1595-1602 (2011 81302507^NSFC^National Natural Science Foundation of China